These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38447251)

  • 21. Childhood osteosarcoma: multimodal therapy in a single-institution Turkish series.
    Ayan I; Kebudi R; Ozger H
    Cancer Treat Res; 2009; 152():319-38. PubMed ID: 20213399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
    Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?
    Tsuda Y; Tsoi K; Stevenson JD; Parry MC; Fujiwara T; Sumathi V; Jeys LM
    Clin Orthop Relat Res; 2020 Jun; 478(6):1190-1198. PubMed ID: 31904683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L; Deng S; Zhang F; Liang Y; Huang Z
    World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?
    Restrepo DJ; Huayllani MT; Boczar D; Sisti A; Spaulding AC; Carter RE; Moran SL; Parker AS; Perdikis G; Forte AJ
    Anticancer Res; 2019 Sep; 39(9):5027-5031. PubMed ID: 31519610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
    Smeland S; Bielack SS; Whelan J; Bernstein M; Hogendoorn P; Krailo MD; Gorlick R; Janeway KA; Ingleby FC; Anninga J; Antal I; Arndt C; Brown KLB; Butterfass-Bahloul T; Calaminus G; Capra M; Dhooge C; Eriksson M; Flanagan AM; Friedel G; Gebhardt MC; Gelderblom H; Goldsby R; Grier HE; Grimer R; Hawkins DS; Hecker-Nolting S; Sundby Hall K; Isakoff MS; Jovic G; Kühne T; Kager L; von Kalle T; Kabickova E; Lang S; Lau CC; Leavey PJ; Lessnick SL; Mascarenhas L; Mayer-Steinacker R; Meyers PA; Nagarajan R; Randall RL; Reichardt P; Renard M; Rechnitzer C; Schwartz CL; Strauss S; Teot L; Timmermann B; Sydes MR; Marina N
    Eur J Cancer; 2019 Mar; 109():36-50. PubMed ID: 30685685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
    Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limb versus life: the outcomes of osteosarcoma in Cambodia.
    Noor S; Thornormóðsson HS; Zervas CT; Ly T; Gollogly J
    Int Orthop; 2014 Mar; 38(3):579-85. PubMed ID: 24305786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary bone sarcomas in patients over 40 years of age: A retrospective study using data from the Bone Tumor Registry of Japan.
    Nagano A; Ishimaru D; Nishimoto Y; Akiyama H; Kawai A
    J Orthop Sci; 2017 Jul; 22(4):749-754. PubMed ID: 28412026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution.
    Wang W; Yang J; Wang Y; Wang D; Han G; Jia J; Xu M; Bi W
    Pathol Res Pract; 2017 Feb; 213(2):119-125. PubMed ID: 28040328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnoses, treatment, and oncologic outcomes in patients with calcaneal malignances: Case series, systematic literature review, and pooled cohort analysis.
    Newman ET; van Rein EAJ; Theyskens N; Ferrone ML; Ready JE; Raskin KA; Lozano Calderon SA
    J Surg Oncol; 2020 Dec; 122(8):1731-1746. PubMed ID: 32974945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to neoadjuvant chemotherapy and survival of children and adolescents with high-grade osteosarcoma treated based on the EURAMOS-1 protocol.
    Suárez-Mattos A; Arroyave F; Infante AM; Narváez C; Soto C; Gómez L; Amaya-Nieto J
    Bol Med Hosp Infant Mex; 2022; 79(1):17-25. PubMed ID: 35086129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Good prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy.
    Hegyi M; Semsei AF; Jakab Z; Antal I; Kiss J; Szendroi M; Csoka M; Kovacs G
    Pediatr Blood Cancer; 2011 Sep; 57(3):415-22. PubMed ID: 21563300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What are the factors that affect survival and relapse after local recurrence of osteosarcoma?
    Takeuchi A; Lewis VO; Satcher RL; Moon BS; Lin PP
    Clin Orthop Relat Res; 2014 Oct; 472(10):3188-95. PubMed ID: 24980644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.
    Berlanga P; Cañete A; Díaz R; Salom M; Baixauli F; Gómez J; Llavador M; Castel V
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):e272-7. PubMed ID: 25374283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone sarcoma incidence in the Netherlands.
    Goedhart LM; Ho VKY; Dijkstra PDS; Schreuder HWB; Schaap GR; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Suurmeijer AJH; Jutte PC
    Cancer Epidemiol; 2019 Jun; 60():31-38. PubMed ID: 30903831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
    Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does increased rate of limb-sparing surgery affect survival in osteosarcoma?
    Ayerza MA; Farfalli GL; Aponte-Tinao L; Muscolo DL
    Clin Orthop Relat Res; 2010 Nov; 468(11):2854-9. PubMed ID: 20559766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes of non-osteogenic, non-Ewing soft-tissue sarcoma of bone--experience of the Toronto Sarcoma Program.
    Veitch ZW; Fasih S; Griffin AM; Al-Ezzi EM; Gupta AA; Ferguson PC; Wunder JS; Abdul Razak AR
    Cancer Med; 2020 Dec; 9(24):9282-9292. PubMed ID: 33063945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of 28 flat bone osteosarcomas: prognostic factors and early and long-term outcome.
    Salas S; Huynh TK; Giorgi R; Deville JL; Bollini G; Curvale G; Blesius A; Gentet JC; Bui B; Bouvier C; Duffaud F
    Eur J Cancer Care (Engl); 2011 May; 20(3):322-9. PubMed ID: 20148934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.